Form: 6-K

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

May 22, 2014

Exhibit 99.3
 
 
 
KPMG LLP
Telephone
  (514) 840-2100
 
600 de Maisonneuve Blvd. West
Fax
  (514) 840-2187
 
Suite 1500
Internet
  www.kpmg.ca
 
Tour KPMG
     
 
Montréal (Québec) H3A 0A3
     
 
 
Consent of Independent Auditor
 
 

The Board of Directors
 
Acasti Pharma Inc.
 
 
We consent to the incorporation by reference in the Registration Statement (File No. 333-191907) on Form F-10 of Acasti Pharma Inc. (the “Company”) of our report dated May 21, 2014, with respect to the financial statements of the Company, which comprise the statements of financial position as at February 28, 2014 and February 28, 2013, the statements of earnings and comprehensive loss, changes in equity and cash flows for the years then ended, and notes, comprising a summary of significant accounting policies and other explanatory information, which report appears on Form 6-K of the Company.
 
 
 
 
May 21, 2014
Montreal, Canada
 

*CPA, auditor, CA, public accountancy permit No. A119178
 
 
 
 
KPMG LLP is a Canadian limited liability partnership and a member firm of the KPMG
network of independent member firms affiliated with KPMG International Cooperative
(“KPMG International”), a Swiss entity.  KPMG Canada provides services to KPMG LLP.